Urgent one-stage endoscopic treatment for choledocholithiasis related moderate to severe acute cholangitis: A propensity score-matched analysis

Table 4 Outcomes of endoscopic retrograde cholangiopancreatography in the propensity matched population (Tokyo score 3 subgroup)

Patients with Grade III AC	Total, n = 58	ERCP ≤ 24 h, n = 35	ERCP > 24 h, n = 23	P value
Duration of antibiotic use (d)	8 (3-28)	7 (3-15)	11 (3-28)	0.004
In-hospital mortality, n (%)	1 (1.7)	0	1 (4.3)	0.213
30-d mortality, n (%)	4 (6.9)	2 (5.7)	2 (8.7)	0.661
Recurrent cholangitis, n (%)	4 (6.9)	2 (5.7)	2 (8.7)	0.661
LOHS, (d)	13 (6-71)	9 (6-17)	20 (14-71)	< 0.001
Required ICU stay, n (%)	32 (55.2)	21 (60)	11 (47.8)	0.362
ICU stay length, (d)	6 (1-71)	4 (1-15)	11 (1-71)	0.014
30 d readmission, n (%)	10 (17.2)	6 (17.1)	4 (17.4)	0.98
ERCP-related complications, n (%)	11 (19)	8 (22.9)	3 (13)	0.351
PEP	4 (6.9)	3 (8.6)	1 (4.3)	0.535
Cholangitis	3 (5.2)	3 (8.6)	0	0.149
Bleeding	2 (3.4)	1 (2.9)	1 (4.3)	0.761
Others	1 (1.7)	1 (2.9)	0	0.414

AC: Acute cholangitis; ERCP: Endoscopic retrograde cholangiopancreatography; LOHS: Length of hospital stay; PEP: Post-endoscopic retrograde cholangiopancreatography pancreatitis; ICU: Intensive care unit.